In the US, Nolvadex (tamoxifen systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Male, Breast Cancer - Metastatic, Breast Cancer - Palliative, McCune-Albright Syndrome and Precocious Puberty.
Ingredient matches for Nolvadex
Tamoxifen is reported as an ingredient of Nolvadex in the following countries:
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Nolvadex in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)